Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma

British Journal of Dermatology

Volumn 151, Issue 2, 2004, Pages 397-406

  Moehrle, M ^a   Kraemer, A ^a   Schippert, W ^a   Garbe, C ^a   Rassner, G ^a   Breuninger, H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Local recurrence; Melanoma; Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL RISK; TUMOR LOCALIZATION; TUMOR VOLUME;

FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 4544317489     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06050.x     Document Type: Article

References (34)

1. Cohn Cedermark G, Mansson BE, Rutqvist LE et al. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study. Cancer 1997; 80: 1418-25.
2. Balch CM, Urist MM, Karakousis CP et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1-4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 1993; 218: 262-7.
3. Karakousis CP, Balch CM, Urist MM et al. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol 1996; 3: 446-52.
4. Evans GR. Manson PN. Review and current perspectives of cutaneous malignant melanoma. J Am Coll Surg 1994; 178: 523-40.
5. Heenan PJ, English DR, Holman CD, Armstrong BK. The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma, Cancer 1992; 69: 421-6.
6. Bachaud JM, Shubinski R, Boussin G et al. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives. Eur J Surg Oncol 1992; 18: 442-8.
7. Balch CM, Soong SJ, Smith T et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001; 8: 101-8.
8. Baughan CA, Hall VL, Leppard BJ et al. Follow-up in stage I cutaneous malignant melanoma: an audit. Clin Oncol (R Coll Radiol) 1993; 5: 174-80.
9. Cascinelli N, Bufalino R, Marolda R et al. Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol 1986; 12: 175-80.
10. Cruse CW, Wells KE, Schroer KR et al. Etiology and prognosis of local recurrence in malignant melanoma of the skin. Ann Plast Surg 1992; 28: 26-8.
11. Fusi S, Ariyan S, Sternlicht A. Data on first recurrence after treatment for malignant melanoma in a large patient population. Plast Reconstr Surg 1993; 91: 94-8.
12. Griffiths RW, Briggs JC. Incidence of locally metastatic ('recurrent') cutaneous malignant melanoma following conventional wide margin excisional surgery for invasive clinical stage I tumours: importance of maximal primary tumour thickness. Br J Surg 1986; 73: 349-53.
13. Heaton KM, Sussman JJ, Gershenwald JE et al. Surgical margins and prognostic factors in patients with thick (> 4 mm) primary melanoma. Ann Surg Oncol 1998; 5: 322-8.
14. Heenan PJ, English DR, Holman CD. The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma [comment]. Cancer 1993; 71: 3792-3.
15. Lukacs L. Loco-regional renewal of malignant melanomas. I. Local recurrence satellites and in-transit nodes. Acta Chir Hung 1992; 33: 325-34.
16. Neades GT, Orr DJ, Hughes LE et al. Safe margins in the excision of primary cutaneous melanoma. Br J Surg 1993; 80: 731-3.
17. Roses DF, Harris MN, Rigel D et al. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg 1983; 198: 65-9.
18. Slingluff CL, Vollmer RT, Reintgen DS et al. Lethal 'thin' malignant melanoma. Identifying patients at risk. Ann Surg 1988; 208: 150-61.
19. Soong SJ, Harrison RA, McCarthy WH et al. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol 1998; 67: 228-33.
20. Urist MM, Balch CM, Soong S et al. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 1985; 55: 1398-402.
21. Eastwood J, Baker TG. Cutaneous malignant melanoma in West Yorkshire: II. A prospective study of recurrence and prediction of lymph nodal metastasis. Br J Cancer 1984; 50: 35-43.
22. Reinigen DS, Cox C, Slingluff CLJ et al. Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Ann Plast Surg 1992; 28: 45-9.
23. Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg 1991; 126: 438-41.
24. Brown CD, Zitelli JA. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol Surg 1995; 21: 285-90.
25. Drzewiecki KT, Andersson AP. Local melanoma recurrences in the scar after limited surgery for primary tumor. World J Surg 1995; 19: 346-9.
26. Orfanos CE, Jung EG, Rassner G et al. Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94. Hautarzt 1994; 45: 285-91.
27. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994; 69: 979-85.
28. O'Brien CJ, Coates AS, Petersen SK et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991; 162: 310-4.
29. Möhrle M, Schippert W, Garbe C et al. Prognostic parameters and surgical strategies for facial melanomas. J German Dermatol Soc 2003; 1: 457-63.
30. Yeung RSW. Recurrent cutaneous melanoma: a surgical perspective. Seminars Oncol 1993; 20: 400-18.
31. Ringborg U, Andersson R, Eldh J et al. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8-2.0 mm: randomized study by the Swedish Melanoma Study Group. Cancer 1996; 77: 1809-14.
32. Veronesi U, Cascinelli N, Adamus J et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988; 318: 1159-62.
33. Markowitz JS, Cosimi LA, Carey RW et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 1991; 126: 703-7.
34. Reintgen DS, Vollmer R, Tso CY et al. Prognosis for recurrent stage I malignant melanoma. Arch Surg 1987; 122: 1338-42.